Monday, April 22, 2013

Commercial Contracts and Chargeback Management

The agenda for CBI’s 2013 Commercial Contracts and Chargeback Management forum has just been released. Lots of good topics, including: 340B, chargeback computations, class-of-trade development, and (of course) healthcare reform.

Speakers come from such companies as American Health Care, Amerinet, Apexus/340B Prime Vendor Program, Auxilium Pharmaceuticals, Cardinal Health, Celgene, Compliance Implementation Services, Daiichi Sankyo, Eisai, Eli Lilly & Company, GS1 Healthcare US, Healthcare Supply Chain Association (HSCA), Horizon Pharma, McKesson, Novo Nordisk, Pfizer, PSS World Medical, Purdue Pharma, Revitas, and more.

Drug Channels readers can register with code FZT663 and save $500. Thanks CBI!


CBI’s 9th Annual Commercial Contracts and Chargeback Management
Optimize Profitability and Streamline Contract Processes with Wholesalers, GPOs and PHS Entities

Over a thousand pharmaceutical and biotech executives have benefitted from CBI’s annual conference – the only forum that focuses on ways to improve the wholesaler chargeback, managed markets contracting and rebate administration process. Gain strategies and tools for streamlining these important processes and ultimately retaining more revenue for the organization.

June 19-20, 2013 * Philadelphia, PA ** Save $500 with code FZT663

No comments:

Post a Comment